Dr. Abass Alavi, a pioneering figure in the field of molecular imaging and nuclear medicine, and his wife Jane Alavi, made a $100,000 donation to our Foundation.
February 13, 2025
BAMF Alzheimer’s patient says he feels privileged to come here and adds, “Now I have a shot.”
February 4, 2025
David was the first person in the United States to receive a new experimental agent to treat pancreatic cancer.
January 22, 2025
FDA-approved treatment is available to those with Alzheimer’s Disease, but only in its earliest stage. We walk through the early signs to look for.
January 9, 2025
We’re taking a look back at 2024’s biggest milestones and accomplishments.
December 27, 2024
BAMF Health is creating a global destination for intelligence-based precision medicine through the construction of a comprehensive Theranostics center in downtown Detroit.
December 17, 2024
Kid Rock’s dad received treatment for prostate cancer at BAMF Health.
December 3, 2024
Jan says he had run out of treatment options for his metastatic prostate cancer, but what he heard when he came to BAMF was hope.
October 29, 2024
Newly published research details BAMF Health’s collaboration with the National Cancer Institute, Leidos Biomedical Research Inc., and Yale University on the Artificial Intelligence and Medical Imaging (AIMI) project.
October 23, 2024
BAMF Health will be a site for Radiopharma Theranostics’ clinical trial and will also be manufacturing 18F-RAD 101 for other trial sites.
October 21, 2024
In celebration of Nuclear Medicine Week, we’re highlighting our phenomenal team of technologists.
October 5, 2024
Partnership increases physician and patient participation in clinical trials
September 16, 2024
BAMF Health patients share personal stories of battling prostate cancer and offer advice to others.
September 3, 2024
The two Potawatomi organizations are both committed to investing in the technology sector and supporting innovation.
August 19, 2024